<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore the delayed neuroprotective effect of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> on the expression of NF-kappaB in rat models of transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Adult male Sprague-Dawley rats (220 approximately 300 g) were randomly assigned into 3 groups:an <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion (I/R) group, and a 2.5% <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> (Sevo1) group, and a 4.0% <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> (Sevo2) group </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the rats were subjected to right middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for 2 hours </plain></SENT>
<SENT sid="3" pm="."><plain>The rats in the I/R group were exposed to pure oxygen 60 min at 24 h before MCAO </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning was induced 24 h before <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> by exposing the rats to 2.5% or 4.0% <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> + oxygen for 60 min </plain></SENT>
<SENT sid="5" pm="."><plain>The effects of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> on the brain was analyzed by evaluating the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and the expression of NF-kappaB protein through 2, 3, 5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> (TTC) staining and immunohistochemistry at 24 and 72 h after the reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were significantly reduced in the Sevo1 and Sevo2 groups at 24 and 72 h after the reperfusion, compared with the I/R group </plain></SENT>
<SENT sid="7" pm="."><plain>The expression of NF-kappaB in the ischemic territory increased after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> could remarkably decrease the expression of NF-kappaB in 24 and 72 h after the reperfusion </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> inhibits the expression of NF-kappaB protein during focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> the reperfusion,which may be part of the mechanism of its delayed neuroprotective function </plain></SENT>
</text></document>